Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2006 09:07 ET | Source: VioQuest Pharmaceuticals

VioQuest Pharmaceuticals Plans NDA Filing for VQD-001

BASKING RIDGE, N.J., June 12, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH), a biopharmaceutical company, plans to submit a New Drug Application (NDA) in 2007 with the U.S. Food...
May 24, 2006 08:45 ET | Source: VioQuest Pharmaceuticals

VioQuest Pharmaceuticals Initiates Clinical Trial for Akt Targeted Therapeutic

BASKING RIDGE, N.J., May 24, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals (OTCBB:VQPH), a New Jersey-based biopharmaceutical company focused on acquiring, developing and commercializing targeted...
May 22, 2006 11:22 ET | Source: VioQuest Pharmaceuticals

VioQuest to Host Analyst Meeting

BASKING RIDGE, N.J., May 22, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH) is hosting an analyst meeting to build awareness of the effects of the over-expression of phosphorylated...
May 19, 2006 09:33 ET | Source: VioQuest Pharmaceuticals

VioQuest Reports First Quarter 2006 Financial Results and Highlights Quarterly Accomplishments

BASKING RIDGE, N.J., May 19, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals (OTCBB:VQPH) a biopharmaceutical company focused on developing and eventually commercializing targeted therapeutics, reported...
May 03, 2006 08:59 ET | Source: VioQuest Pharmaceuticals

VioQuest Pharmaceutical's Investigational New Drug Application Accepted by the FDA For Targeted AKT/Anti-Cancer Therapeutic

BASKING RIDGE, N.J., May 3, 2006 (PRIMEZONE) -- VioQuest Pharmaceutical's (OTCBB:VQPH) Investigational New Drug (IND) application was accepted for VQD-002, triciribine-phosphate (TCN-P) by the U.S....
April 26, 2006 08:38 ET | Source: VioQuest Pharmaceuticals

VioQuest Pharmaceuticals Appoints Two Industry Veterans to Its Scientific Advisory Board

Basking Ridge, N.J., April 26, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals (OTCBB:VQPH), a New Jersey-based biopharmaceutical company focused on acquiring, developing and commercializing targeted...
April 11, 2006 15:37 ET | Source: VioQuest Pharmaceuticals

VioQuest Pharmaceuticals Discusses Targeted Therapeutics For Cancer on News 12 New Jersey

BASKING RIDGE, N.J., April 11, 2006 (PRIMEZONE) -- Pamela Harris, M.D., Chief Medical Officer and Dick Welter, Ph.D., Vice President of Corporate Business Development of VioQuest Pharmaceuticals...
April 10, 2006 09:05 ET | Source: VioQuest Pharmaceuticals

VioQuest Pharmaceuticals to Present at BIO 2006 in Chicago

BASKING RIDGE, N.J., April 10, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH), a New Jersey-based biopharmaceutical company focused on acquiring, developing and commercializing...
March 15, 2006 08:30 ET | Source: VioQuest Pharmaceuticals

VioQuest Pharmaceuticals Appoints an Industry Veteran as Chief Medical Officer

BASKING RIDGE, N.J., March 15, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH) has named Pamela Harris, MD, to the role of chief medical officer. Dr. Harris brings to VioQuest...
March 09, 2006 10:52 ET | Source: VioQuest Pharmaceuticals

VioQuest Pharmaceuticals to Present at the Sachs North America Forum for Investing and Partnering in Biotech and Medtech

BASKING RIDGE, N.J., March 9, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH), a New Jersey-based biopharmaceutical company focused on acquiring, developing and commercializing...